Beta Drugs Ltd

Fri 23/10/2026,15:54:32 | NSE : BETA

₹1894.60-76.40 (-3.88%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 1973.00

Previous Close

₹ 1971.00

Volume

155586

Mkt Cap ( ₹ Cr)

₹ 2100.33

High

₹ 1973.00

Low

₹ 1823.00

52 Week High

₹ 2807.90

52 Week Low

₹ 990.10

Book Value Per Share

₹ 236.52

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Beta Drugs Ltd

Your Vote -

Buy

75.00%

Hold

12.50%

Sell

12.50%

75.00%

8 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Beta Drugs Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Beta Drugs - Analysts/Institutional Investor Meet/Con. Call Updates

    22 Oct 2026, 6:00PM Beta Drugs Limited has informed the Exchange about Link of Recording
  • Beta Drugs - Statement of deviation(s) or variation(s) under Reg. 32

    22 Oct 2026, 5:38PM Beta Drugs Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
  • Beta Drugs - Analysts/Institutional Investor Meet/Con. Call Updates

    22 Oct 2026, 12:12PM Beta Drugs Limited has informed the Exchange about Presentation
  • Beta Drugs - Outcome of Board Meeting

    22 Oct 2026, 11:14AM Beta Drugs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
  • Beta Drugs - Analysts/Institutional Investor Meet/Con. Call Updates

    16 Oct 2026, 8:21PM Beta Drugs Limited has informed the Exchange about Schedule of meet
  • Beta Drugs - Analysts/Institutional Investor Meet/Con. Call Updates

    16 Oct 2026, 7:15PM Beta Drugs Limited has informed the Exchange about Schedule of meet
  • Beta Drugs has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2026

    16 Oct 2026, 12:50PM As of September 2026, 58.91% is owned by Indian Promoters and 41.09% by Public. <p align=justify> Top five Promoters holding highest number of shares
  • Beta Drugs - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    6 Oct 2026, 10:26AM Beta Drugs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Beta Drugs - Shareholders meeting

    1 Oct 2026, 3:59PM Beta Drugs Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company ha
  • Beta Drugs - Trading Window

    30 Sep 2026, 11:38AM Beta Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
  • Beta Drugs - Shareholders meeting

    30 Sep 2026, 11:35AM Beta Drugs Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026
  • Beta Drugs - General Updates

    22 Sep 2026, 9:00AM Beta Drugs Limited has informed the Exchange about Azerbaijan Oncology Market Regulatory & Commercialisation update
  • Beta Drugs - Analysts/Institutional Investor Meet/Con. Call Updates

    10 Sep 2026, 3:15PM Beta Drugs Limited has informed the Exchange about Schedule of meet
  • Beta Drugs - Copy of Newspaper Publication

    7 Sep 2026, 10:34AM Beta Drugs Limited has informed the Exchange about Copy of Newspaper Publication
  • Beta Drugs - Shareholders meeting

    5 Sep 2026, 4:16PM Beta Drugs Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026
  • Beta Drugs - General Updates

    3 Sep 2026, 6:10PM Beta Drugs Limited has informed the Exchange about 'Beta Drugs Limited has informed the Exchange that Register of Members & Share Transfer Books of t
  • Beta Drugs - Shareholders meeting

    3 Sep 2026, 6:05PM Beta Drugs Limited has informed the Exchange regarding Notice of undefined to be held on September 30, 2026
  • Beta Drugs - Outcome of Board Meeting

    3 Sep 2026, 5:56PM Beta Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on September 03, 2026.
  • Beta Drugs - Outcome of Board Meeting

    18 Aug 2026, 12:07PM Beta Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on August 18, 2026.
  • Beta Drugs - Monitoring Agency Report

    14 Aug 2026, 12:29PM Monitoring Agency Report for the Quarter ended 30th June, 2026
  • Beta Drugs - Investor Presentation

    27 Jul 2026, 9:24PM Beta Drugs Limited has informed the Exchange about Investor Presentation
  • Beta Drugs - Reply to Clarification- Financial results

    23 Jul 2026, 5:54PM The Exchange had sought clarification from Beta Drugs Limited for the quarter ended 30-Jun-2026 with respect to Regulation 33 of the SEBI (Listing Obl

Key fundamentals

Evaluate the intrinsic value of Beta Drugs Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 279.9453 252.8384 119.6301 99.984 82.6124
Liabilities 279.9453 252.8384 119.6301 99.984 82.6124
Equity 10.1369 10.0945 9.6138 9.6138 9.6138
Gross Profit 28.5443 31.416 33.5256 31.1981 25.1837
Net Profit 14.3345 15.4321 21.9366 18.8161 14.2465
Cash From Operating Activities 19.1973 18.0425 21.1872 10.2264 18.7625
NPM(%) 6.35 7 11.1 11.91 11.41
Revenue 225.4295 220.1996 197.6207 157.8746 124.8468
Expenses 196.8852 188.7835 164.0951 126.6765 99.6631
ROE(%) 5.46 5.88 8.36 7.17 5.43

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Beta Drugs Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 763.70 -2.63 19.31 0.00 -26.19 0.65
Lotus Eye Hospital and Institute Ltd 112.40 1.47 1605.71 0.00 0.39 0.00
Vaishali Pharma Ltd 6.87 -4.98 21.47 0.00 15.42 0.00
Astec Lifesciences Ltd 663.70 -0.82 0.00 0.00 -363.14 0.00

Company Info

The Company was incorporated as ?Beta Drugs Private limited? at Himachal Pradesh as a private limited company under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated September 21, 2005 bearing Corporate Identification Number U24230HP2005PTC28969 issued by Registrar of Companies, Punjab, Himachal Pradesh and Chandigarh. Subsequently, the Company was converted in to public limited company pursuant to Shareholders Resolution passed at the Extra-Ordinary General Meeting of the Company held on July 24, 2017 and the name of the Company was changed to ?Beta Drugs Limited? pursuant to issuance of fresh Certificate of Incorporation consequent upon conversion of Company from Private to Public Limited dated August 11, 2017 issued by the Registrar of Companies, Himachal Pradesh. The Corporate Identification Number of the Company is U24230HP2005PLC028969. KEY EVENTS AND MILESTONES IN THE HISTORY OF THE COMPANY 2005 -Incorporation of the Company as Beta Drugs Private Limited 2014 -Vijay Kumar Batra, existing promoter took over the Company 2015 -ISO: 9001:2008 Certification for manufacturing and supply of Pharmaceutical products such as Oncology Sterile Injections and Lyophilized Injections and Oncology solid oral medication tablets and capsules -Certificate of Good Manufacturing Practice from Health and Family Welfare Department, Himachal Pradesh 2016 -Certificate of Good Manufacturing Practice from Republic of Kenya 2017 -Conversion of Company into Public Limited Company. 2024 -The Company Earns Forbes Asia ""Best Under a Billion"" 2024 Award for Third Consecutive Year, 2025 -The Company has issued Bonus Shares in the Ratio of 1:20.

The Company was incorporated as ?Beta Drugs Private limited? at Himachal Pradesh as a private limited company under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated September 21, 2005 bearing Corporate Identification Number U24230HP2005PTC28969 issued by Registrar of Companies, Punjab, Himachal Pradesh and Chandigarh. Subsequently, the Company was converted in to public limited company pursuant to Shareholders Resolution passed at the Extra-Ordinary General Meeting of the Company held on July 24, 2017 and the name of the Company was changed to ?Beta Drugs Limited? pursuant to issuance of fresh Certificate of Incorporation consequent upon conversion of Company from Private to Public Limited dated August 11, 2017 issued by the Registrar of Companies, Himachal Pradesh. The Corporate Identification Number of the Company is U24230HP2005PLC028969. KEY EVENTS AND MILESTONES IN THE HISTORY OF THE COMPANY 2005 -Incorporation of the Company as Beta Drugs Private Limited 2014 -Vijay Kumar Batra, existing promoter took over the Company 2015 -ISO: 9001:2008 Certification for manufacturing and supply of Pharmaceutical products such as Oncology Sterile Injections and Lyophilized Injections and Oncology solid oral medication tablets and capsules -Certificate of Good Manufacturing Practice from Health and Family Welfare Department, Himachal Pradesh 2016 -Certificate of Good Manufacturing Practice from Republic of Kenya 2017 -Conversion of Company into Public Limited Company. 2024 -The Company Earns Forbes Asia ""Best Under a Billion"" 2024 Award for Third Consecutive Year, 2025 -The Company has issued Bonus Shares in the Ratio of 1:20.

Parent Organisation

Beta Drugs Ltd.

Founded

21/09/2015

Managing Director

Mr.Varun Batra

NSE Symbol

BETAEQ

FAQ